Kerstin Valinder-Strinnholm

Directeur/Membre du Conseil chez KVS Invest AB

Profil

Kerstin Valinder-Strinnholm currently works at Immedica Pharma AB, as Director from 2020, KVS Invest AB, as Director, Cavastor AB, as Director, and Pollux Pharma AB, as Deputy Director.
Ms. Valinder-Strinnholm also formerly worked at Moberg Pharma AB, as Chairman from 2022 to 2025, KLIFO A, as Director, Bioservo Technologies AB, as Independent Director from 2021 to 2023, Promore Pharma AB, as Independent Director, Mendus AB, as Independent Director from 2016 to 2020, Corline Biomedical AB, as Independent Non-Executive Director, Gedea Biotech AB, as Director, Camurus AB, as Independent Director from 2015 to 2024, AstraZeneca PLC, as Principal, Astra AB, as Principal, Takeda A, as Executive Vice President-Business Development, Takeda Pharmaceuticals International AG, as Executive Vice President-Business Development, and Nycomed AB, as Executive Vice President-Business Development.
Ms. Valinder-Strinnholm received her undergraduate degree from the University of Gothenburg.

Postes actifs de Kerstin Valinder-Strinnholm

Sociétés	Poste	Début
KVS Invest AB	Directeur/Membre du Conseil	-
Cavastor AB	Directeur/Membre du Conseil	-
Pollux Pharma AB	Corporate Officer/Principal	-
Immedica Pharma AB	Directeur/Membre du Conseil	01/11/2020

Anciens postes connus de Kerstin Valinder-Strinnholm

Sociétés	Poste	Fin
MOBERG PHARMA AB	Président	22/05/2025
CAMURUS AB	Directeur/Membre du Conseil	08/05/2024
BIOSERVO TECHNOLOGIES AB	Directeur/Membre du Conseil	18/12/2023
MENDUS AB	Directeur/Membre du Conseil	01/01/2020
Gedea Biotech AB	Directeur/Membre du Conseil	-